Your browser doesn't support javascript.
loading
Rituximab use in pediatric systemic lupus erythematosus: Indications, efficacy and safety in an Indian cohort.
Sawhney, Sujata; Agarwal, Manjari.
Affiliation
  • Sawhney S; Division of Pediatric Rheumatology, 28928Sir Ganga Ram Hospital, Institute of Child Health, Sir Ganga Ram Hospital, New Delhi, India.
  • Agarwal M; Division of Pediatric Rheumatology, 28928Sir Ganga Ram Hospital, Institute of Child Health, Sir Ganga Ram Hospital, New Delhi, India.
Lupus ; 30(11): 1829-1836, 2021 Oct.
Article in En | MEDLINE | ID: mdl-34315295
Subject(s)
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Rituximab / Immunologic Factors / Lupus Erythematosus, Systemic Type of study: Observational_studies Limits: Adolescent / Child / Female / Humans / Male Country/Region as subject: Asia Language: En Journal: Lupus Journal subject: REUMATOLOGIA Year: 2021 Type: Article Affiliation country: India
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Rituximab / Immunologic Factors / Lupus Erythematosus, Systemic Type of study: Observational_studies Limits: Adolescent / Child / Female / Humans / Male Country/Region as subject: Asia Language: En Journal: Lupus Journal subject: REUMATOLOGIA Year: 2021 Type: Article Affiliation country: India